Differentiating Hereditary Hemochromatosis (HFE) from Megaloblastic and Pernicious Anemia
These are fundamentally different diseases with opposite iron profiles: hereditary hemochromatosis causes iron overload with elevated transferrin saturation (>45-55%) and elevated ferritin, while megaloblastic/pernicious anemia typically presents with normal or low iron stores, macrocytic anemia, and specific vitamin B12/folate deficiencies.
Key Distinguishing Laboratory Features
Iron Studies - The Primary Differentiator
Hereditary Hemochromatosis:
- Transferrin saturation >45% in women, >50% in men 1
- Elevated serum ferritin (>200 µg/L in women, >300 µg/L in men) 1
- Normal or elevated hemoglobin (polycythemia occurs in ~28% of HFE patients) 2, 3
- Iron overload pattern on liver biopsy or MRI if performed
Megaloblastic/Pernicious Anemia:
- Normal or low transferrin saturation
- Normal or low serum ferritin (reflecting depleted iron stores from chronic anemia)
- Macrocytic anemia with elevated MCV
- Low vitamin B12 levels (pernicious anemia)
- Positive intrinsic factor antibodies or anti-parietal cell antibodies
- Elevated methylmalonic acid and homocysteine
Complete Blood Count Pattern
The CBC provides immediate differentiation:
- HFE hemochromatosis: Normal hemoglobin or polycythemia (mean Hgb 15.0 mg/dL), normocytic RBCs 2, 3
- Megaloblastic anemia: Low hemoglobin, macrocytic RBCs (MCV >100 fL), hypersegmented neutrophils on peripheral smear
Genetic Testing
For HFE hemochromatosis, genetic confirmation is definitive 1, 4:
- Test for C282Y homozygosity (85-90% of HFE cases) 5
- C282Y/H63D compound heterozygosity (minority of cases)
- Autosomal recessive inheritance pattern
Pernicious anemia has no specific genetic mutation testing; diagnosis relies on antibody testing and B12 levels.
Clinical Presentation Differences
HFE Hemochromatosis presents with:
- Hepatomegaly, cirrhosis risk
- Diabetes mellitus
- Arthropathy (especially metacarpophalangeal joints)
- Skin hyperpigmentation ("bronze diabetes")
- Cardiomyopathy
- Hypogonadism
- Often asymptomatic until organ damage occurs 5, 1
Pernicious Anemia presents with:
- Fatigue, weakness from anemia
- Neurological symptoms (peripheral neuropathy, subacute combined degeneration)
- Glossitis, angular cheilitis
- Atrophic gastritis
- No hepatomegaly or skin pigmentation changes
Diagnostic Algorithm
Order fasting transferrin saturation and serum ferritin as initial screening 1, 6, 4
If transferrin saturation >45-55% AND elevated ferritin:
If macrocytic anemia with normal/low iron studies:
- Check vitamin B12, folate levels
- Check methylmalonic acid and homocysteine
- Test for intrinsic factor antibodies and anti-parietal cell antibodies
- Consider bone marrow biopsy if diagnosis unclear (shows megaloblastic changes)
Critical Clinical Pitfall
The rare paradoxical association: Case reports document that pernicious anemia can mask hemochromatosis manifestations 8, 9. The atrophic gastritis in pernicious anemia causes iron malabsorption, which may prevent iron overload despite HFE mutations 8. In these exceptional cases:
- Ferritin may be only moderately elevated despite C282Y homozygosity 9
- Both macrocytic anemia AND elevated ferritin may coexist
- Genetic testing becomes essential to identify the dual pathology 9
When both conditions coexist, the cytologic presentation of pernicious anemia (macrocytosis, hypersegmented neutrophils) remains unchanged, but iron overload is attenuated and responds rapidly to phlebotomy 9.
Treatment Implications
The distinction is critical because treatments are completely different:
- HFE hemochromatosis: Therapeutic phlebotomy to reduce iron stores 5, 6, 7
- Pernicious anemia: Vitamin B12 replacement (never phlebotomy, which would worsen anemia)
Bottom line: Measure transferrin saturation and ferritin first. Elevated values point to hemochromatosis (confirm with HFE genetic testing), while normal/low values with macrocytic anemia point to megaloblastic causes (confirm with B12/folate and antibody testing).